Information Provided By:
Fly News Breaks for June 20, 2016
SPNC
Jun 20, 2016 | 07:12 EDT
After meeting with Spectranetics' management, Stifel thinks that new additions to the company's management team, along with "highly encouraging data" on its Stellarex drug-coated balloon, has left the company better positioned to meet or exceed its financial guidance. The firm keeps a $22 price target and Buy rating on the shares.
News For SPNC From the Last 2 Days
There are no results for your query SPNC